Stay updated on Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4. This is a small metadata update indicating a new build or update to the page, not a substantive change to content.
    Difference
    0.0%
    Check dated 2026-05-18T03:48:31.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page’s software/version label has been updated from “Revision: v3.5.0” to “Revision: v3.5.3,” reflecting an interface or release change rather than an update to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-26T15:18:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added 'Multiple myeloma' as a disease descriptor and included a link to the Genetic and Rare Diseases Information Center as a patient resource.
    Difference
    0.1%
    Check dated 2026-03-28T14:03:51.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T09:08:24.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T18:26:15.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.4.1 to v3.4.2. No other visible changes to study content or layout are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:12.000Z thumbnail image

Stay in the know with updates to Ixazomib Citrate for Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ixazomib Citrate for Relapsed Myeloma Clinical Trial page.